We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.07B
AUM Growth
-$7.29M
Cap. Flow
-$13.7M
Cap. Flow %
-1.27%
Top 10 Hldgs %
45.79%
Holding
55
New
Increased
24
Reduced
20
Closed

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$5.47M
2
SYY icon
Sysco
SYY
+$4.42M
3
BAX icon
Baxter International
BAX
+$3.68M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.4M
5
AAPL icon
Apple
AAPL
+$2.22M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$17.4M
2
MMM icon
3M
MMM
+$13.1M
3
NVO
Novo Nordisk
NVO
+$3.83M
4
MDT icon
Medtronic
MDT
+$2.39M
5
BDX icon
Becton Dickinson
BDX
+$2.25M

Sector Composition

Rank Sector Weight
1 Technology 29.5%
2 Healthcare 20.95%
3 Consumer Staples 18.45%
4 Industrials 14.39%
5 Consumer Discretionary 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
1
Oracle
ORCL
$432B
$60.8M 5.67%
1,409,733
+32,633
+2% +$1.41M
MSFT icon
2
Microsoft
MSFT
$3.66T
$56.1M 5.23%
1,380,845
+47,990
+4% +$2.09M
MDT icon
3
Medtronic
MDT
$115B
$50.9M 4.74%
652,150
-31,524
-5% -$2.39M
CSCO icon
4
Cisco
CSCO
$485B
$49.6M 4.63%
1,802,936
+20,686
+1% +$582K
RTX icon
5
RTX Corp
RTX
$298B
$47.7M 4.44%
646,343
+10,155
+2% +$758K
BDX icon
6
Becton Dickinson
BDX
$49.2B
$47.5M 4.43%
339,271
-16,037
-5% -$2.25M
AAPL icon
7
Apple
AAPL
$4.4T
$47.1M 4.4%
1,515,536
+73,640
+5% +$2.22M
WMT icon
8
Walmart Inc
WMT
$914B
$47.1M 4.39%
1,718,004
+21,600
+1% +$613K
PG icon
9
Procter & Gamble
PG
$336B
$43M 4.01%
524,314
-2,659
-0.5% -$229K
OMC icon
10
Omnicom Group
OMC
$23.4B
$41.3M 3.85%
529,551
-15,607
-3% -$1.19M
CHRW icon
11
C.H. Robinson
CHRW
$17.2B
$40.8M 3.8%
557,299
+20,652
+4% +$1.51M
MMM icon
12
3M
MMM
$94.7B
$38.7M 3.61%
280,415
-95,145
-25% -$13.1M
KO icon
13
Coca-Cola
KO
$375B
$36.1M 3.36%
890,006
-19,903
-2% -$832K
ACN icon
14
Accenture
ACN
$109B
$35.9M 3.34%
382,775
+14,750
+4% +$1.32M
VAR
15
DELISTED
Varian Medical Systems, Inc.
VAR
$35.6M 3.32%
431,737
+13,663
+3% +$1.1M
NVO
16
Novo Nordisk
NVO
$203B
$33.9M 3.16%
1,268,764
-166,466
-12% -$3.83M
JNJ icon
17
Johnson & Johnson
JNJ
$630B
$32.3M 3.01%
320,937
-6,633
-2% -$675K
IBM icon
18
IBM
IBM
$220B
$30.3M 2.83%
197,512
-5,898
-3% -$895K
NKE icon
19
Nike
NKE
$60.4B
$30.2M 2.81%
601,820
-14,090
-2% -$674K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.09T
$27.8M 2.59%
192,834
+3,643
+2% +$536K
BAX icon
21
Baxter International
BAX
$14B
$27.6M 2.58%
742,468
+96,962
+15% +$3.68M
PEP icon
22
PepsiCo
PEP
$188B
$27.4M 2.56%
286,994
+56,492
+25% +$5.47M
SYY icon
23
Sysco
SYY
$40.6B
$24.3M 2.26%
643,542
+112,203
+21% +$4.42M
MCD icon
24
McDonald's
MCD
$195B
$22.2M 2.07%
227,507
-183,300
-45% -$17.4M
CTSH icon
25
Cognizant
CTSH
$26B
$21.3M 1.99%
341,622
-6
-0% -$354

Similar funds

Saratoga Research & Investment Management's Q1 2015 Portfolio in Review

As of Q1 2015, Saratoga Research & Investment Management held 55 positions worth $1.07B, down 0.68% from $1.08B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Trading was light in Q1 2015: portfolio turnover was 0%. Saratoga Research & Investment Management opened no new positions and made no exits, leaving the 55-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management added most to PepsiCo in Q1 2015, an estimated $5.47M increase.
  • Saratoga Research & Investment Management's biggest Q1 2015 reduction was McDonald's, cutting an estimated $17.4M.
  • Saratoga Research & Investment Management's ten largest holdings make up 46% of its $1.07B portfolio in Q1 2015.
  • Saratoga Research & Investment Management opened 0 new positions and closed 0 in Q1 2015.
  • Saratoga Research & Investment Management's portfolio value fell 0.68% quarter-over-quarter to $1.07B.

Based on Saratoga Research & Investment Management's 13F filing for Q1 2015, filed 28 Apr 2015.